Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated Post date May 16, 2022 — 08:44 Post Lock Read More Li Ning is also in the game! Why are the traditional chain giants all interested in your coffee money? -Finance-financial world Post date May 14, 2022 — 19:54 Post Lock Read More Pay 499 yuan, Li Ning will send you a cup of coffee Post date May 14, 2022 — 19:11 Post Lock Read More The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value Post date May 14, 2022 — 13:05 Post Lock Read More The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net Post date May 14, 2022 — 11:00 Post Lock Read More Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline Post date May 13, 2022 — 21:04 Post Lock Read More The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network Post date May 13, 2022 — 20:12 Post Lock Read More Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Li Ning is also in the game! Why are the traditional chain giants all interested in your coffee money? -Finance-financial world Post date May 14, 2022 — 19:54 Post Lock Read More Pay 499 yuan, Li Ning will send you a cup of coffee Post date May 14, 2022 — 19:11 Post Lock Read More The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value Post date May 14, 2022 — 13:05 Post Lock Read More The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net Post date May 14, 2022 — 11:00 Post Lock Read More Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline Post date May 13, 2022 — 21:04 Post Lock Read More The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network Post date May 13, 2022 — 20:12 Post Lock Read More Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pay 499 yuan, Li Ning will send you a cup of coffee Post date May 14, 2022 — 19:11 Post Lock Read More The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value Post date May 14, 2022 — 13:05 Post Lock Read More The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net Post date May 14, 2022 — 11:00 Post Lock Read More Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline Post date May 13, 2022 — 21:04 Post Lock Read More The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network Post date May 13, 2022 — 20:12 Post Lock Read More Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value Post date May 14, 2022 — 13:05 Post Lock Read More The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net Post date May 14, 2022 — 11:00 Post Lock Read More Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline Post date May 13, 2022 — 21:04 Post Lock Read More The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network Post date May 13, 2022 — 20:12 Post Lock Read More Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net Post date May 14, 2022 — 11:00 Post Lock Read More Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline Post date May 13, 2022 — 21:04 Post Lock Read More The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network Post date May 13, 2022 — 20:12 Post Lock Read More Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline Post date May 13, 2022 — 21:04 Post Lock Read More The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network Post date May 13, 2022 — 20:12 Post Lock Read More Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network Post date May 13, 2022 — 20:12 Post Lock Read More Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world Post date May 10, 2022 — 22:40 Post Lock Read More Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net Post date May 10, 2022 — 13:11 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure Post date May 9, 2022 — 09:01 Post Lock Read More Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly Post date May 9, 2022 — 08:58 Post Lock Read More Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network Post date May 9, 2022 — 08:47 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News Post date May 7, 2022 — 15:50 Post Lock Read More 31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com Post date May 7, 2022 — 15:48 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive Post date May 7, 2022 — 15:46 Post Lock Read More 8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? Post date May 7, 2022 — 15:45 Post Lock Read More April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed. Post date May 7, 2022 — 10:53 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More
Caishen.CoCaishen.Co